MIMP
Grupo de Imaxe Molecular e Física Médica
Publicacións (150) Publicacións nas que participase algún/ha investigador/a
2024
-
Biodistribution and pharmacokinetics of [89Zr]-anti-VEGF mAbs using PET in glioblastoma rat models
International Journal of Pharmaceutics, Vol. 652
-
Partial volume correction in longitudinal tau PET studies: is it really needed?
NeuroImage, Vol. 289
-
Perspectives of the European Association of Nuclear Medicine on the role of artificial intelligence (AI) in molecular brain imaging
European Journal of Nuclear Medicine and Molecular Imaging
2023
-
A murine model of BSCL2-associated Celia's encephalopathy
Neurobiology of Disease, Vol. 187
-
Association of periodontitis with cognitive decline and its progression: Contribution of blood-based biomarkers of Alzheimer's disease to this relationship
Journal of Clinical Periodontology, Vol. 50, Núm. 11, pp. 1444-1454
-
Description of a different quantification method for amyloid burden (burdenDPD) and validation of SPECT/CT in cardiac amyloidosis
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 171-177
-
EANM position paper: theranostics in brain tumours—the present and the future
European Journal of Nuclear Medicine and Molecular Imaging
-
FDA approval of lecanemab: the real start of widespread amyloid PET use? — the EANM Neuroimaging Committee perspective
European Journal of Nuclear Medicine and Molecular Imaging
-
First experimental measurements of 2D microdosimetry maps in proton therapy
Medical Physics, Vol. 50, Núm. 1, pp. 570-581
-
Increased Medial Temporal Tau Positron Emission Tomography Uptake in the Absence of Amyloid-β Positivity
JAMA neurology
-
Pharmacokinetic Evaluation of New Drugs Using a Multi-Labelling Approach and PET Imaging: Application to a Drug Candidate with Potential Application in Neuromuscular Disorders
Biomedicines, Vol. 11, Núm. 2
-
Prevalencia de dislipemia aterogénica, factores relacionados y grado de control lipídico en la población general de Galicia: Estudio GALIPEMIAS
Clínica e investigación en arteriosclerosis, Vol. 35, Núm. 4, pp. 178-184
-
Quantitative PET tracking of intra-articularly administered 89Zr-peptide-decorated nanoemulsions
Journal of Controlled Release, Vol. 356, pp. 702-713
-
Role of systemic inflammatory factors in gastroenteropancreatic neuroendocrine tumors (GEP-NETs) treated with peptide receptor radionuclide therapy (PRRT): From biology to theragnosis
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 42, Núm. 3, pp. 156-162
2022
-
18F-florbetapir PET as a marker of myelin integrity across the Alzheimer’s disease spectrum
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 4, pp. 1242-1253
-
Charge collection efficiency, underlying recombination mechanisms, and the role of electrode distance of vented ionization chambers under ultra-high dose-per-pulse conditions
Physica Medica, Vol. 104, pp. 10-17
-
Cysteamine Eye Drops in Hyaluronic Acid Packaged in Innovative Single-Dose Systems: Stability and Ocular Biopermanence
Pharmaceutics, Vol. 14, Núm. 10
-
Development of Improved Dosimetry Standards for FLASH Radiotherapy: The UHDpulse Project
Proceedings of the 14th International Conference on Radiation Shielding and 21st Topical Meeting of the Radiation Protection and Shielding Division, ICRS 2022/RPSD 2022
-
Development of an ultra-thin parallel plate ionization chamber for dosimetry in FLASH radiotherapy
Medical Physics, Vol. 49, Núm. 7, pp. 4705-4714
-
Dose-response assessment of cerebral P-glycoprotein inhibition in vivo with [18F]MC225 and PET
Journal of Controlled Release, Vol. 347, pp. 500-507